Monday, 10 May 2021

Vivimed Labs Gains On Receiving Government's Approval To Make Favipiravir

Favipiravir is indicated to treat mild to moderate cases of Covid-19 infection and is in short supply owing to rising Covid-19 infections in the country.

from NDTV Profit - Latest https://ift.tt/3xXjdHV
via

No comments:

Post a Comment